FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival
2007 · Clinical Cancer Research · 286 citations
https://doi.org/10.1158/1078-0432.ccr-07-0122
D
Dmitry Turbin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
3.6K
Citations
30
h-index
36
i10-index
Dmitry Turbin is an academic researcher. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Breast Cancer Treatment Studies. The author has an h-index of 30, co-authored 46 publications.
Papers by this author
worksStromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
2007 · Breast Cancer Research and Treatment · 218 citations
https://doi.org/10.1007/s10549-007-9546-3
Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2006 · Cancer Research · 156 citations
https://doi.org/10.1158/0008-5472.can-05-3561
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
2008 · Breast Cancer Research · 122 citations
https://doi.org/10.1186/bcr2156
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysis
2009 · BMC Cancer · 85 citations
https://doi.org/10.1186/1471-2407-9-165
MDM2 protein expression is a negative prognostic marker in breast carcinoma
2005 · Modern Pathology · 76 citations
https://doi.org/10.1038/modpathol.3800484
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat